Zacks Research Issues Negative Estimate for IDEX Earnings

IDEX Corporation (NYSE:IEX) – Equities researchers at Zacks Research cut their Q3 2026 earnings per share estimates for IDEX in a report issued on Tuesday, August 25th. Zacks Research analyst Team now anticipates that the industrial products company will post earnings of $2.19 per share for the quarter, down from their prior estimate of $2.20. The consensus estimate for IDEX’s current full-year earnings is $8.82 per share. Zacks Research also issued estimates for IDEX’s Q2 2027 earnings at $2.34 EPS and Q2 2028 earnings at $2.45 EPS.

IDEX (NYSE:IEX) last issued its quarterly earnings results on Wednesday, July 29th. The industrial products company reported $2.32 earnings per share for the quarter, topping the consensus estimate of $2.11 by $0.21. IDEX had a return on equity of 15.69% and a net margin of 14.49%.The firm had revenue of $920.60 million during the quarter, compared to the consensus estimate of $905.38 million. During the same period last year, the company earned $2.07 earnings per share. The company’s revenue for the quarter was up 6.4% on a year-over-year basis. IDEX has set its FY 2026 guidance at 8.700-8.850 EPS and its Q3 2026 guidance at 2.200-2.250 EPS.

A number of other research analysts have also issued reports on the stock. Mizuho upgraded shares of IDEX from a “neutral” rating to an “outperform” rating and boosted their price target for the stock from $210.00 to $280.00 in a research note on Tuesday, August 11th. Royal Bank Of Canada raised their price objective on shares of IDEX from $261.00 to $280.00 and gave the company an “outperform” rating in a research report on Thursday, July 30th. Seaport Research Partners reaffirmed a “buy” rating and issued a $250.00 price objective on shares of IDEX in a report on Tuesday, May 5th. Weiss Ratings upgraded IDEX from a “hold (c+)” rating to a “buy (b-)” rating in a research report on Thursday, July 30th. Finally, Oppenheimer reissued an “outperform” rating and issued a $265.00 price target on shares of IDEX in a report on Thursday, July 30th. Eight investment analysts have rated the stock with a Buy rating and two have assigned a Hold rating to the stock. According to data from MarketBeat.com, the company has a consensus rating of “Moderate Buy” and a consensus target price of $260.80.

IDEX Stock Up 2.0%

Shares of IDEX stock opened at $234.91 on Thursday. IDEX has a one year low of $158.19 and a one year high of $243.80. The company has a market cap of $17.32 billion, a P/E ratio of 33.80, a PEG ratio of 2.17 and a beta of 0.98. The company has a debt-to-equity ratio of 0.46, a quick ratio of 2.15 and a current ratio of 3.05. The firm has a fifty day moving average of $228.47 and a two-hundred day moving average of $213.48.

IDEX Dividend Announcement

The business also recently disclosed a quarterly dividend, which was paid on Friday, July 24th. Investors of record on Monday, July 6th were issued a dividend of $0.73 per share. The ex-dividend date of this dividend was Monday, July 6th. This represents a $2.92 dividend on an annualized basis and a yield of 1.2%. IDEX’s payout ratio is currently 42.01%.

Insider Buying and Selling

In other IDEX news, CAO Lisa M. Anderson sold 385 shares of the company’s stock in a transaction dated Wednesday, August 12th. The shares were sold at an average price of $238.59, for a total transaction of $91,857.15. Following the transaction, the chief accounting officer directly owned 4,327 shares in the company, valued at approximately $1,032,378.93. This represents a 8.17% decrease in their ownership of the stock. The sale was disclosed in a filing with the SEC, which can be accessed through this link. Corporate insiders own 0.50% of the company’s stock.

Institutional Investors Weigh In On IDEX

Several institutional investors have recently modified their holdings of IEX. Laurel Wealth Advisors LLC acquired a new position in IDEX during the fourth quarter worth $27,000. Optiver Holding B.V. purchased a new stake in IDEX during the first quarter worth $27,000. SJS Investment Consulting Inc. grew its holdings in IDEX by 104.1% in the first quarter. SJS Investment Consulting Inc. now owns 149 shares of the industrial products company’s stock valued at $28,000 after purchasing an additional 76 shares during the last quarter. Quantbot Technologies LP acquired a new stake in IDEX in the second quarter valued at $33,000. Finally, CYBER HORNET ETFs LLC purchased a new position in shares of IDEX in the second quarter valued at $35,000. Hedge funds and other institutional investors own 97.96% of the company’s stock.

Key Headlines Impacting IDEX

Here are the key news stories impacting IDEX this week:

• Positive Sentiment: Zacks increased its FY2026 EPS estimate to $8.71 from $8.70, Q4 2026 to $2.20 from $2.18, and Q1 2027 to $2.12 from $2.11.
• Positive Sentiment: Longer-term estimates also improved: FY2027 EPS rose to $9.26 from $9.21, Q4 2027 to $2.42 from $2.38, Q1 2028 to $2.38 from $2.36, and FY2028 to $10.54 from $10.45. The revisions imply continued earnings growth, although the increases were relatively small.
• Positive Sentiment: The revised FY2026 estimate of $8.71 remains close to the broader analyst consensus of $8.82. IDEX’s latest reported quarter also showed earnings and revenue ahead of expectations, with EPS of $2.32 and revenue of $920.6 million, up 6.4% year over year.
• Neutral Sentiment: The six Zacks updates largely repeat the same forecast changes rather than representing separate fundamental developments. Investors may view them as supportive, but the limited size of the revisions may constrain their impact.
• Neutral Sentiment: IDEX shares have increased and are trading near the upper end of their 52-week range, above both their 50-day and 200-day moving averages. With a market capitalization of approximately $17.3 billion and a forward-looking valuation near 27 times earnings, further gains may depend on the company converting the raised forecasts into actual results.
• Neutral Sentiment: A separate report concerns IDEX Biometrics ASA (OTC: IDXAF), which granted incentive subscription rights to two senior employees. That company is unrelated to IDEX Corporation and should not affect IEX shares. IDEX Biometrics executive incentive rights announcement

IDEX Company Profile

IDEX Corporation is a diversified industrial manufacturer specializing in the design, production and distribution of highly engineered fluidics systems, measurement technologies and safety solutions. The company’s core offerings include positive-displacement pumps, flow meters, valves, sampling systems and analytical instruments that serve a wide range of end markets such as water treatment, chemical processing, energy, food and beverage, and life sciences. Through its focus on precision engineering and proprietary material science, IDEX delivers products designed for reliability in demanding applications.

Operations at IDEX are organized into three principal segments.